Home » Topics » Regulatory

Regulatory
RSS

FDA approves Triferic for iron replacement and hemoglobin maintenance in CKD

Jan. 27, 2015

FDA approves Natpara for treatment of hypocalcemia in patients with hypoparathyroidism

Jan. 27, 2015

China approves Epidaza for peripheral T-cell lymphoma

Jan. 13, 2015

Cosentyx approved in Japan for psoriasis and psoriatic arthritis

Dec. 30, 2014

Takecab approved for the treatment of acid-related diseases in Japan

Dec. 30, 2014

FDA approves Namzaric for Alzheimer's disease

Dec. 29, 2014

Liraglutide approved in U.S. for weight loss

Dec. 24, 2014

European marketing approval granted to Clinuvel's Scenesse

Dec. 23, 2014

FDA approves AbbVie's Viekira Pak for chronic genotype 1 HCV infection

Dec. 23, 2014

U.S. approval for Cubist's ceftolozane/tazobactam for cUTI and cIAI

Dec. 22, 2014